Showing 1 - 10 of 36
The ageing process in OECD countries calls for a better understanding of the future disease prevalence, life expectancy and patterns of inequalities in health outcomes. In this paper we present the results obtained from several dynamic microsimulation models of the Future Elderly Model (FEM)...
Persistent link: https://www.econbiz.de/10014089895
Persistent link: https://www.econbiz.de/10012489038
Since the seminal paper by Ruhm (2000), a large body of literature agrees on the existence of pro-cyclical fluctuation between economy's performance and mortality, and this evidence has been confirmed also during the Great Recession (GR). In this study we identify a series of important...
Persistent link: https://www.econbiz.de/10012926157
Persistent link: https://www.econbiz.de/10013279430
Medical utilization, such as a count of hospitalizations, is routinely used as a health proxy for both policy and research purposes. Over time, trends in how medicine is practiced has impacted this relationship, as technological improvements or policy changes have altered hospitalizations at the...
Persistent link: https://www.econbiz.de/10012868558
Understanding the role that drug adherence has on health outcomes in everyday clinical practice is central for the policy maker. This is particularly true when patients suffer from asymptomatic chronic conditions (i.e., hypertension, hypercholesterolemia, and diabetes). By exploiting a unique...
Persistent link: https://www.econbiz.de/10014186394
Persistent link: https://www.econbiz.de/10011326807
Persistent link: https://www.econbiz.de/10009614536
This article examines the long term physical and mental health effects of internal migration focusing on a relatively unique migration experience from Southern and Northeastern regions of Italy to Northwestern regions and to the region around Rome concentrated over a relatively short period from...
Persistent link: https://www.econbiz.de/10013076187
Throughout history, technological progress has transformed population health, but the distributional effects of these gains are unclear. New substitutes for older, more expensive health technologies can produce convergence in population health outcomes, but may also be prone to “elite...
Persistent link: https://www.econbiz.de/10012893126